摘要
急性心力衰竭症候群患者耗费了大量的医疗资源,对其本人、家庭和社会带来了巨大的经济负担。在传统药物基础上,利钠肽、醛固酮受体拮抗剂、钙增敏及钾通道开放剂、内皮素和血管加压素拮抗剂等新药的应用对于这类患者治疗疗效的提高引起了广泛的关注。现对此作一简单介绍。
Large amounts of medical and health resources have been devoted to patients with acute heart failure syndromes （ AHFS ）. Substantial financial and personal burdens have been placed on patients and society. Despite the traditional therapy used for AHFS, many acute therapeutic interventions are yet to be validated in randomized controlled trials, although recent years have seen a number of large-scale studies and the introduction of several new treatment options. This article describes briefly the new therapy used for AHFS.
出处
《心血管病学进展》
CAS
2007年第4期565-569,共5页
Advances in Cardiovascular Diseases
关键词
急性心力衰竭症候群
利钠肽
醛固酮受体拮抗剂
钙增敏及钾通道开放剂
内皮素拮抗剂
血管加压素拮抗剂
炎症细胞因子拮抗剂
acute heart failure syndromes
natriuretic peptide
aldosterone receptor antagonist
calcium-sensitizing inotropic agent
endothelin receptor antagonist
vasopressin antagonists
inflammatory cell infiltration antagonist
